This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignee: Kowa Company Limited. Active years: 2010-2013.
Location History:
- Tokyo, JP (2010)
- Higashimurayama, JP (2013)
Company Filing History:
Years Active: 2010-2013
Title: Yuichiro Tabunoki: Innovator in Medical Therapeutics
Introduction
Yuichiro Tabunoki is a prominent inventor based in Higashimurayama, Japan. He has made significant contributions to the field of medical therapeutics, particularly in the development of innovative drugs aimed at treating various diseases. With a total of 2 patents to his name, his work is recognized for its potential impact on healthcare.
Latest Patents
Tabunoki's latest patents include a pyridine-3-carboxyamide derivative, which serves as a novel JAK3 inhibitor. This invention is particularly useful as a preventive and therapeutic agent for conditions such as organ transplantation rejection, rheumatoid arthritis, multiple sclerosis, and several autoimmune diseases. The compound is represented by a specific general formula and can be utilized in various therapeutic applications. Another significant patent focuses on preventives and remedies for myeloma tumors. This invention provides a drug that contains an osteopontin-production regulator or inhibitor, along with a diagnostic kit for measuring blood osteopontin levels, which is crucial for diagnosing myeloma tumors.
Career Highlights
Yuichiro Tabunoki is currently associated with Kowa Company Limited, where he continues to innovate and develop new therapeutic solutions. His work is characterized by a commitment to addressing complex medical challenges through scientific research and invention.
Collaborations
He collaborates with notable colleagues such as Takahiro Kitamura and Hajime Yamada, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yuichiro Tabunoki's contributions to medical therapeutics through his patents highlight his role as a key inventor in the field. His innovative approaches to treating serious health conditions demonstrate the importance of research and development in advancing healthcare solutions.